PHOENIX--(BUSINESS WIRE)--Synovics Pharmaceuticals, Inc., (OTCBB:SYVC), a specialty pharmaceutical company, today announced that it has formed a strategic alliance with Harcharan (Harry) Singh, who is the President and CEO of Glopec International, a privately held international trading and investment company based in Ontario, Canada. Under terms of the agreement, Synovics’ operating subsidiary, Kirk Pharmaceuticals, LLC received an investment of $1,250,000 from an affiliate of Singh. Synovics also announced that Singh will consult with the Company and its board of directors on matters including sourcing low-cost active pharmaceutical ingredients and bulk pharmaceutical finished products; providing access to OTC and prescription drug candidates developed in India and China; and other issues related to the pharmaceutical industry and business operations.
